BusinessCo-Diagnostics Reports Q1 2026 Financial Results
Co-Diagnostics announced its financial results for the first quarter of 2026, highlighting progress in global commercialization through CoSara regulatory advancements and regional expansion. The company is executing its clinical strategy with preparations for upper respiratory submission and tuberculosis-related initiatives.
Menafn·


